G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 59 NOK 0.34%
Market Cap: 909.8m NOK

Income Statement

Earnings Waterfall
Gentian Diagnostics ASA

Income Statement
Gentian Diagnostics ASA

Rotate your device to view
Income Statement
Currency: NOK
Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
Revenue
28
N/A
33
+17%
33
+0%
37
+11%
40
+9%
35
-13%
36
+4%
39
+7%
48
+24%
54
+12%
60
+12%
60
+0%
63
+5%
67
+5%
75
+12%
79
+5%
83
+6%
84
+1%
90
+7%
95
+7%
102
+6%
113
+11%
117
+4%
126
+8%
135
+8%
142
+5%
146
+3%
147
+0%
152
+4%
158
+4%
163
+3%
173
+6%
Gross Profit
Cost of Revenue
(7)
(6)
(6)
(11)
(9)
(17)
(22)
(23)
(10)
(30)
(30)
(31)
(33)
(32)
(38)
(42)
(43)
(44)
(47)
(49)
(73)
(56)
(57)
(60)
(79)
(70)
(72)
(71)
(69)
(67)
(75)
(78)
Gross Profit
21
N/A
27
+32%
26
-3%
26
-2%
31
+20%
18
-43%
15
-18%
16
+12%
38
+133%
24
-36%
30
+24%
29
-2%
31
+6%
34
+12%
37
+6%
37
+1%
40
+8%
40
-1%
42
+6%
46
+9%
29
-37%
56
+95%
60
+6%
65
+9%
57
-14%
72
+28%
75
+3%
76
+2%
83
+9%
91
+10%
89
-3%
95
+7%
Operating Income
Operating Expenses
(37)
(45)
(47)
(41)
(47)
(34)
(34)
(40)
(65)
(50)
(51)
(51)
(49)
(50)
(53)
(53)
(63)
(65)
(69)
(75)
(52)
(76)
(75)
(74)
(64)
(80)
(79)
(76)
(67)
(66)
(69)
(72)
Selling, General & Administrative
(27)
(25)
(27)
(23)
(39)
(20)
(14)
(14)
(49)
(30)
(33)
(33)
(41)
(42)
(42)
(43)
(43)
(38)
(41)
(42)
(47)
(44)
(43)
(46)
(52)
(48)
(50)
(47)
(50)
(50)
(51)
(53)
Research & Development
(4)
0
0
(5)
(4)
(10)
(15)
(15)
(3)
(16)
(16)
(17)
(4)
0
0
0
(11)
0
0
0
(4)
0
0
0
(4)
(5)
(9)
(14)
(18)
(17)
(18)
(19)
Depreciation & Amortization
(3)
(3)
(3)
(4)
(4)
(5)
(5)
(6)
(6)
(6)
(6)
(6)
(7)
(7)
(7)
(8)
(7)
(7)
(8)
(8)
(10)
(11)
(10)
(10)
(10)
(8)
(7)
(5)
(4)
(4)
(4)
(4)
Other Operating Expenses
(3)
(17)
(16)
(9)
(0)
(0)
1
(6)
(6)
2
4
5
3
(1)
(4)
(2)
(2)
(19)
(19)
(24)
9
(22)
(21)
(17)
1
(18)
(12)
(10)
5
5
5
5
Operating Income
(16)
N/A
(17)
-7%
(20)
-18%
(15)
+25%
(16)
-2%
(17)
-5%
(19)
-16%
(24)
-26%
(27)
-12%
(26)
+3%
(21)
+20%
(22)
-6%
(18)
+20%
(15)
+14%
(17)
-10%
(16)
+3%
(23)
-39%
(25)
-10%
(26)
-5%
(28)
-8%
(23)
+18%
(20)
+15%
(15)
+26%
(8)
+45%
(7)
+11%
(7)
-2%
(4)
+46%
(0)
+99%
16
N/A
25
+58%
20
-20%
23
+17%
Pre-Tax Income
Interest Income Expense
1
1
1
1
1
1
1
1
1
2
2
1
0
(2)
(2)
(2)
(2)
(1)
0
(0)
(0)
2
1
2
2
2
2
3
4
1
1
1
Non-Reccuring Items
0
0
0
0
(5)
(5)
(19)
(19)
(14)
(14)
0
0
0
0
0
0
0
0
0
0
0
0
0
1
(6)
0
0
0
0
0
0
0
Total Other Income
0
3
3
2
(0)
(2)
(4)
(4)
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
(0)
(0)
(0)
0
0
0
Pre-Tax Income
(15)
N/A
(14)
+10%
(16)
-20%
(12)
+27%
(20)
-64%
(23)
-17%
(41)
-78%
(46)
-11%
(40)
+13%
(38)
+4%
(19)
+50%
(21)
-9%
(17)
+17%
(17)
+4%
(19)
-12%
(19)
+1%
(25)
-32%
(26)
-7%
(26)
+2%
(29)
-10%
(24)
+17%
(18)
+25%
(14)
+22%
(5)
+62%
(10)
-100%
(6)
+46%
(2)
+69%
3
N/A
20
+702%
26
+30%
21
-20%
24
+14%
Net Income
Tax Provision
(0)
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
25
23
21
19
Income from Continuing Operations
(15)
(14)
(16)
(12)
(20)
(23)
(41)
(46)
(40)
(38)
(19)
(21)
(17)
(17)
(19)
(19)
(25)
(26)
(26)
(29)
(24)
(18)
(14)
(5)
(11)
(6)
(2)
2
45
49
42
43
Net Income (Common)
(15)
N/A
(14)
+10%
(16)
-20%
(12)
+27%
(20)
-64%
(23)
-17%
(41)
-78%
(46)
-11%
(40)
+13%
(38)
+4%
(19)
+50%
(21)
-9%
(17)
+17%
(17)
+4%
(19)
-12%
(19)
+1%
(25)
-32%
(26)
-7%
(26)
+2%
(29)
-10%
(24)
+17%
(18)
+25%
(14)
+22%
(5)
+62%
(11)
-105%
(6)
+45%
(2)
+66%
2
N/A
45
+1 940%
49
+8%
42
-14%
43
+1%
EPS (Diluted)
-1.08
N/A
-0.99
+8%
-1.18
-19%
-0.78
+34%
-1.29
-65%
-1.52
-18%
-2.68
-76%
-2.98
-11%
-2.59
+13%
-2.48
+4%
-1.25
+50%
-1.36
-9%
-1.13
+17%
-1.09
+4%
-1.23
-13%
-1.22
+1%
-1.61
-32%
-1.72
-7%
-1.68
+2%
-1.85
-10%
-1.53
+17%
-1.14
+25%
-0.89
+22%
-0.33
+63%
-0.69
-109%
-0.37
+46%
-0.13
+65%
0.13
N/A
2.87
+2 108%
3.11
+8%
2.73
-12%
2.75
+1%